Russell Investments Group’s Mural Oncology MURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,922
Closed -$2.42K 3921
2025
Q1
$2.42K Sell
1,922
-3,585
-65% -$13.1K ﹤0.01% 3485
2024
Q4
$17.7K Buy
5,507
+237
+4% +$836 ﹤0.01% 3034
2024
Q3
$16.5K Buy
5,270
+2,557
+94% +$8.33K ﹤0.01% 2996
2024
Q2
$8.52K Buy
2,713
+1,554
+134% +$5.73K ﹤0.01% 3106
2024
Q1
$5.67K Sell
1,159
-277
-19% -$1.34K ﹤0.01% 2922
2023
Q4
$8.5K Buy
+1,436
New +$5.77K ﹤0.01% 2844

Other funds holding MURA

Russell Investments Group's MURA Position: Q2 2025 in Review

Russell Investments Group sold out of Mural Oncology (MURA) in Q2 2025, closing a stake of 1,922 shares — an estimated $2.42K sold.

Russell Investments Group first reported a position in MURA in Q4 2023 and held it in 6 quarters. The position peaked at $17.7K in Q4 2024. 66 funds tracked by Wall St. Rank hold MURA as of Q2 2025.

  • Russell Investments Group reported no remaining Mural Oncology position as of Q2 2025 after selling out during the quarter.
  • Russell Investments Group sold 1,922 Mural Oncology shares in Q2 2025, an estimated $2.42K.
  • Russell Investments Group first reported a position in Mural Oncology in Q4 2023 and held it in 6 quarters.
  • Russell Investments Group's Mural Oncology position peaked at $17.7K in Q4 2024.
  • 66 funds tracked by Wall St. Rank held Mural Oncology as of Q2 2025.

Based on Russell Investments Group's 13F filing for Q2 2025, filed 13 Aug 2025.